Department of Surgery, Duke University, Durham, North Carolina 27710, USA.
J Am Coll Cardiol. 2012 Oct 9;60(15):1315-22. doi: 10.1016/j.jacc.2011.11.081. Epub 2012 Aug 29.
Surgical approaches to correct mitral regurgitation (MR) have evolved over 50 years and form much of the basis for percutaneous approaches to the mitral valve. Surgical mitral repairs have been more durable with use of annuloplasty, but recurrent regurgitation not resulting in reoperation can occur. The mitral leaflets may be resected or augmented, with recent trends to preserve leaflet coaptation surfaces if possible. Mitral chords tend to be replaced or transferred instead of being shortened. Mitral replacement still has a role when more durable and reliable than repair. Surgical incisions have varied from full sternotomy down to percutaneous access only, with less invasiveness usually requiring a trade-off versus effectiveness or ease of application. Less invasive options in treating MR may encourage higher-risk patients to seek anatomic therapy, whether surgical or percutaneous. Rapidly evolving technology will continue to be a dominant driver of surgical approaches to MR, with increasing overlap and interaction with percutaneous approaches.
50 多年来,治疗二尖瓣反流(MR)的手术方法不断发展,为二尖瓣经皮治疗方法奠定了基础。二尖瓣环成形术的应用使外科二尖瓣修复术更加持久,但仍可能出现不导致再次手术的复发性反流。二尖瓣瓣叶可以切除或增强,最近的趋势是尽可能保留瓣叶对合面。二尖瓣腱索倾向于替换或转移,而不是缩短。当修复术比置换术更持久和可靠时,置换术仍有其作用。手术切口从完全胸骨切开术到仅经皮入路不等,微创性通常需要权衡有效性或应用的便利性。治疗 MR 的微创选择可能会鼓励更高风险的患者寻求解剖治疗,无论是外科手术还是经皮治疗。快速发展的技术将继续成为治疗 MR 的手术方法的主要驱动力,与经皮治疗方法的重叠和相互作用越来越多。